tiprankstipranks
Trending News
More News >

Syngene International Achieves Record Quarterly Revenue with Strong Year-End Performance

Story Highlights
Syngene International Achieves Record Quarterly Revenue with Strong Year-End Performance

Confident Investing Starts Here:

Syngene International Ltd. ( (IN:SYNGENE) ) has issued an update.

Syngene International Limited reported an 11% increase in fourth-quarter revenue, reaching Rs. 1,018 crore, marking the first time quarterly revenue exceeded Rs. 1,000 crore. The full-year revenue saw a 4% rise to Rs. 3,642 crore, although profit after tax before exceptional items decreased by 8% to Rs. 475 crore. Despite the decline in annual profit, the company’s operational growth and revenue milestones reflect its robust performance and strategic market positioning.

More about Syngene International Ltd.

Syngene International Limited operates in the biotechnology industry, providing integrated research, development, and manufacturing services. The company focuses on delivering solutions to pharmaceutical, biotechnology, and agrochemical sectors, enhancing its market presence through innovation and strategic partnerships.

YTD Price Performance: -16.27%

Average Trading Volume: 46,039

Current Market Cap: 296B INR

For detailed information about SYNGENE stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App